TITLE:
      Sertraline and Naltrexone for Alcohol Dependence
SUMMARY:
      This study is a double-blind, placebo-controlled outpatient trial to improve, through the
      addition of sertraline (Zoloft), the abstinence and relapse rates in alcohol- dependent
      individuals currently taking naltrexone (Revia).
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Meets the criteria for alcohol dependence.

          -  Abstinent from alcohol for a period of at least 5 days and not greater than 30 days.

          -  Able to read English and complete study evaluations.

          -  A stable residence and a telephone to ensure that subjects can be located during the
             study.

        Exclusion Criteria:

          -  Currently meets criteria for substance abuse or dependence with the exception of
             nicotine dependence.

          -  Current use of disulfiram (Antabuse) or a MAO Inhibitor.

          -  Psychotic or otherwise severely psychiatrically disabled (i.e., depressed, suicidal,
             current mania).

          -  Major depression at the time of assessment.

          -  Previous treatment with naltrexone (Revia) for alcohol dependence.

          -  Significant underlying medical conditions such as cerebral, renal, thyroid, or
             cardiac disease.

          -  Abstinent longer than 30 days prior to admission to program.

          -  Hepatocellular disease or elevated bilirubin levels.

          -  Females who are pregnant, nursing, or not using a reliable method of birth control.
